Dea No. 9733

Dea No. 9733 Brand names, Dea No. 9733 Analogs

Dea No. 9733 Brand Names Mixture

No information avaliable

Dea No. 9733 Chemical_Formula

C₁₇H₂₃NO

Dea No. 9733 RX_link

http://www.rxlist.com/cgi/generic2/levorphanol.htm

Dea No. 9733 fda sheet

Dea No. 9733 msds (material safety sheet)

Dea_No._9733 MSDS

Dea No. 9733 Synthesis Reference

Woods LA, et al. J Pharmacol Exp Ther. 1958 Sep;124(1):1-8.

Dea No. 9733 Molecular Weight

257.371 g/mol

Dea No. 9733 Melting Point

198-199 ^oC

Dea No. 9733 H₂O Solubility

1840 mg/L

Dea No. 9733 State

Solid

Dea No. 9733 LogP

3.986

Dea No. 9733 Dosage Forms

Tablet

Dea No. 9733 Indication

For the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate

Dea No. 9733 Pharmacology

Levorphanol is a potent synthetic opioid analgesic indicated for the management of moderate to severe pain or as a preoperative medication where an opioid analgesic is appropriate. Levorphanol is similar to morphine in its actions, however it is up to 8 times more potent than morphine. Levorphanol produces a degree of respiratory depression similar to that produced by morphine at equianalgesic doses, and like many mu-opioid drugs, levorphanol produces euphoria or has a positive effect on mood in many individuals.

Dea No. 9733 Absorption

Levorphanol is well absorbed after PO administration with peak plasma concentrations occurring approximately 1 hour after dosing.

Dea No. 9733 side effects and Toxicity

LD₅₀=150 mg/kg (orally in rats). Signs of overdose include nausea, emesis, dizziness, respiratory depression, hypotension, urinary retention, cardiac arrhythmias, allergic reactions, skin rash, and uticaria.

Dea No. 9733 Patient Information

No information avaliable

Dea No. 9733 Organisms Affected

Humans and other mammals